Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Giuseppe Lombardi, MD, PhD

Advertisement

Articles by Giuseppe Lombardi, MD, PhD

Quality of Life Is an Important Endpoint in Cancer Trials

ByGiuseppe Lombardi, MD, PhD
June 22nd 2019

Health-related quality of life (QOL) is becoming an increasingly important endpoint in cancer clinical trials.

Advertisement

Latest Updated Articles

  • Quality of Life Is an Important Endpoint in Cancer Trials
    Quality of Life Is an Important Endpoint in Cancer Trials

    June 22nd 2019



Advertisement
Advertisement

Trending on Oncology Nursing News

1

How An Adaptive Weight-Loss Strategy Benefits Breast Cancer Survivors

2

Cancer Surgery Waiting Times Rising: What Oncology Nurses Need to Know

3

Advances in Lymphoma Care: Experts Breakdown CAR T-Cell Therapy, Bispecifics, and CLL Management

4

Active Surveillance Rates Rise for Prostate Cancer in Veterans Health System

5

Integrating Emerging Evidence into Frontline Metastatic Triple-Negative Breast Cancer Care

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us